These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 23374348)

  • 21. Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents.
    Saleh N; Ibrahim P; Clark T
    Angew Chem Int Ed Engl; 2017 Jul; 56(31):9008-9012. PubMed ID: 28481446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active state-like conformational elements in the beta2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs.
    Han DS; Wang SX; Weinstein H
    Biochemistry; 2008 Jul; 47(28):7317-21. PubMed ID: 18558776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
    Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
    Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
    Simpson LM; Wall ID; Blaney FE; Reynolds CA
    Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insights into agonist-induced activation of G-protein-coupled receptors.
    Deupi X; Standfuss J
    Curr Opin Struct Biol; 2011 Aug; 21(4):541-51. PubMed ID: 21723721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX.
    West GM; Chien EY; Katritch V; Gatchalian J; Chalmers MJ; Stevens RC; Griffin PR
    Structure; 2011 Oct; 19(10):1424-32. PubMed ID: 21889352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation.
    Dong SS; Goddard WA; Abrol R
    Biophys J; 2016 Jun; 110(12):2618-2629. PubMed ID: 27332120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.
    Yao XJ; Vélez Ruiz G; Whorton MR; Rasmussen SG; DeVree BT; Deupi X; Sunahara RK; Kobilka B
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9501-6. PubMed ID: 19470481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
    Kim JM; Hwa J; Garriga P; Reeves PJ; RajBhandary UL; Khorana HG
    Biochemistry; 2005 Feb; 44(7):2284-92. PubMed ID: 15709741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β₂-adrenergic receptor activation by agonists studied with ¹⁹F NMR spectroscopy.
    Horst R; Liu JJ; Stevens RC; Wüthrich K
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10762-5. PubMed ID: 23956158
    [No Abstract]   [Full Text] [Related]  

  • 34. Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.
    Chung KY; Rasmussen SG; Liu T; Li S; DeVree BT; Chae PS; Calinski D; Kobilka BK; Woods VL; Sunahara RK
    Nature; 2011 Sep; 477(7366):611-5. PubMed ID: 21956331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of the orthosteric ligands binding on the conformational dynamics of the B-2-adrenergic receptor by means of essential dynamics sampling simulation].
    Novikov GV; Sivozhelezov VS; Shaitan KV
    Mol Biol (Mosk); 2014; 48(3):463-79. PubMed ID: 25831896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
    Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B
    Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
    Vilar S; Karpiak J; Berk B; Costanzi S
    J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propagation of conformational changes during μ-opioid receptor activation.
    Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
    Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist-bound structures of G protein-coupled receptors.
    Lebon G; Warne T; Tate CG
    Curr Opin Struct Biol; 2012 Aug; 22(4):482-90. PubMed ID: 22480933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.